Fertility Testing Is Big Business—But Is It Really Helping You Get Pregnant?
By Elissa Strauss,
Glamour Magazine [cites CGS' Fellow Gina Maranto]
| 12. 28. 2017
New evidence shows that the tests many companies use to determine a woman's chances of having a baby are based on bogus science.
"Learn how many high quality eggs you have remaining and your chances of getting pregnant now and in the future,” beckons Egg-Q, one of the handful of new startups offering fertility testing to women concerned about their reproductive potential. The desire to know “how long you have left to conceive,” as offered by LetsGetChecked, or, more simply, “powerful information about your fertility,” courtesy of Modern Fertility, is understandable. Women are having children later than ever, a shift that has proved professionally and personally beneficial, but reproductively challenging. When offered a fertility magic eight ball, many can’t help but take a peek, hoping to discover something, anything, about their baby-making future.
If only that was possible.
These fertility blood tests provide women with an assortment of figures and graphs charting their ovarian reserve, along with a few other measures that will present themselves as authoritative, fate-determining even. But in reality, they offer little more than...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...